相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of concurrent medications on outcomes with PD1/PD-L1 inhibitors for metastatic urothelial carcinoma.
Archana Agarwal et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
Arielle Elkrief et al.
ONCOIMMUNOLOGY (2019)
Prognostic impact of the use of antibiotics in patients with advanced non-small cell lung cancer (NSCLC) receiving PD-(L)1 targeting monoclonal antibodies
A. Schett et al.
ANNALS OF ONCOLOGY (2019)
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
Sha Zhao et al.
LUNG CANCER (2019)
Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer
Arsela Prelaj et al.
EUROPEAN JOURNAL OF CANCER (2019)
Impact of prior antibiotic use on the efficacy of nivolumab for non-small cell lung cancer
Taiki Hakozaki et al.
ONCOLOGY LETTERS (2019)
Antibiotic treatment prior to immune checkpoint inhibitor therapy as a tumor-agnostic predictive correlate of response in routine clinical practice.
David James Pinato et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC (vol 28, pg 1339, 2017)
J. J. Knox et al.
ANNALS OF ONCOLOGY (2018)
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L. Derosa et al.
ANNALS OF ONCOLOGY (2018)
Antibiotic use and outcomes with systemic therapy in metastatic renal cell carcinoma (mRCC).
Aly-Khan A. Lalani et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cancer immunotherapy beyond immune checkpoint inhibitors
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
Florian Huemer et al.
Oncotarget (2018)
Cumulative antibiotic use and efficacy of immune checkpoint inhibitors in patients with advanced cancer.
Nadina Tinsley et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Antibiotic use and overall survival in lung cancer patients receiving nivolumab.
Tien Phuc Do et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prognostic markers for progression free survival (PFS) to anti PD-1 therapies in metastatic melanoma
Umang Swami et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Ming Yi et al.
MOLECULAR CANCER (2018)
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
Alexandra Thomas et al.
ONCOIMMUNOLOGY (2018)
Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials
S. Sen et al.
ANNALS OF ONCOLOGY (2018)
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer
Hui Yu et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Antibiotic Use Does Not Appear to Influence Response to Nivolumab
Coureche Kaderbhai et al.
ANTICANCER RESEARCH (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
Immune Checkpoint Inhibitors in Older Adults
Rawad Elias et al.
CURRENT ONCOLOGY REPORTS (2016)
Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Katri Korpela et al.
NATURE COMMUNICATIONS (2016)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses
Nikola Panic et al.
PLOS ONE (2013)
Intestinal Commensal Microbes as Immune Modulators
Ivaylo I. Ivanov et al.
CELL HOST & MICROBE (2012)
Interactions Between the Microbiota and the Immune System
Lora V. Hooper et al.
SCIENCE (2012)
Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome
Hedvig E. Jakobsson et al.
PLOS ONE (2010)
Fixed-versus random-effects models in meta-analysis: Model properties and an empirical comparison of differences in results
Frank L. Schmidt et al.
BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY (2009)
A microtubule interactome: Complexes with roles in cell cycle and mitosis
Julian R. Hughes et al.
PLOS BIOLOGY (2008)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
分享论文
